InvestMoat

UnitedHealth vs CVS

CVS is growing faster. So why does UnitedHealth win?

UnitedHealth edges it, 67 to 66, on moat.

CVS wins on growth and valuation, but UnitedHealth's lead on moat counts for more.

UNH · Healthcare

UnitedHealth Group Inc.

…

Speculative BuyFull analysis

CVS · Healthcare

CVS Health Corporation

…

Speculative BuyFull analysis

UNH

CVS

Composite
67
(higher)
66
Moat
79
(higher)
65
Growth
54
60
(higher)
Valuation
74
77
(higher)

UNH

CVS

Bear
$300
$65
Base
$470
$105
Bull
$620
$135
Upside to base
—
—

UNH

CVS

Revenue CAGR, 3–5 yr
3-6%
3-6%

UNH

CVS

Proprietary Data
Strong (higher)
Intact
Regulatory Lock-In
Weakened
Intact (higher)
Network Effects
Strong (higher)
Intact
Transaction Embedding
Intact
Intact
System of Record
Strong (higher)
Intact
Scale Economics
Intact
Intact
Brand & Pricing Power
N/A
N/A

UNH

CVS

Learned Interfaces
Intact
Intact
Business Logic
Intact
Intact
Public Data Access
N/A
N/A
Talent Scarcity
Intact
Intact
Bundling
Strong (higher)
Intact

Shaded cells mark the higher score or stronger moat on each row. Valuation and composite use the live price when it is available, the same as each stock page.

Which is the better stock, UnitedHealth or CVS?

UnitedHealth edges it, 67 to 66, on moat. CVS wins on growth and valuation, but UnitedHealth's lead on moat counts for more. Our rating: UnitedHealth Speculative Buy, CVS Speculative Buy.

Does UnitedHealth or CVS have the wider moat?

UnitedHealth scores 79 on moat to CVS's 65. UnitedHealth is rated stronger on proprietary data, network effects and system of record. CVS is rated stronger on regulatory lock-in.

Which is growing faster, UnitedHealth or CVS?

CVS scores 60 on growth to UnitedHealth's 54. We expect UnitedHealth to grow 3–6% a year, CVS 3–6%.

Is UnitedHealth or CVS cheaper right now?

CVS scores 77 on valuation to UnitedHealth's 74. In our base case, CVS has more upside: +22% vs +16%.

Scores in the answers use the price each valuation was last struck at; the table above updates with the live price. Not investment advice.